Logo image of MCRI

MONARCH CASINO & RESORT INC (MCRI) Stock Fundamental Analysis

USA - NASDAQ:MCRI - US6090271072 - Common Stock

99.11 USD
-1.29 (-1.28%)
Last: 10/7/2025, 8:00:01 PM
99.11 USD
0 (0%)
After Hours: 10/7/2025, 8:00:01 PM
Fundamental Rating

6

Overall MCRI gets a fundamental rating of 6 out of 10. We evaluated MCRI against 135 industry peers in the Hotels, Restaurants & Leisure industry. MCRI scores excellent points on both the profitability and health parts. This is a solid base for a good stock. MCRI has a decent growth rate and is not valued too expensively. These ratings could make MCRI a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

MCRI had positive earnings in the past year.
In the past year MCRI had a positive cash flow from operations.
Each year in the past 5 years MCRI has been profitable.
MCRI had a positive operating cash flow in each of the past 5 years.
MCRI Yearly Net Income VS EBIT VS OCF VS FCFMCRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

With an excellent Return On Assets value of 11.15%, MCRI belongs to the best of the industry, outperforming 87.41% of the companies in the same industry.
The Return On Equity of MCRI (14.59%) is better than 73.33% of its industry peers.
The Return On Invested Capital of MCRI (17.60%) is better than 88.15% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MCRI is in line with the industry average of 15.70%.
The 3 year average ROIC (16.41%) for MCRI is below the current ROIC(17.60%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.15%
ROE 14.59%
ROIC 17.6%
ROA(3y)11.75%
ROA(5y)9.74%
ROE(3y)15.45%
ROE(5y)13.62%
ROIC(3y)16.41%
ROIC(5y)13.04%
MCRI Yearly ROA, ROE, ROICMCRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

MCRI's Profit Margin of 14.72% is amongst the best of the industry. MCRI outperforms 87.41% of its industry peers.
MCRI's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 24.09%, MCRI belongs to the best of the industry, outperforming 88.15% of the companies in the same industry.
In the last couple of years the Operating Margin of MCRI has grown nicely.
MCRI has a Gross Margin of 54.43%. This is in the better half of the industry: MCRI outperforms 64.44% of its industry peers.
MCRI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 24.09%
PM (TTM) 14.72%
GM 54.43%
OM growth 3Y-1.11%
OM growth 5Y7.55%
PM growth 3Y-7%
PM growth 5Y1.78%
GM growth 3Y-0.78%
GM growth 5Y1.1%
MCRI Yearly Profit, Operating, Gross MarginsMCRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

7

2. Health

2.1 Basic Checks

MCRI has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, MCRI has less shares outstanding
Compared to 5 years ago, MCRI has more shares outstanding
There is no outstanding debt for MCRI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MCRI Yearly Shares OutstandingMCRI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MCRI Yearly Total Debt VS Total AssetsMCRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 8.92 indicates that MCRI is not in any danger for bankruptcy at the moment.
MCRI's Altman-Z score of 8.92 is amongst the best of the industry. MCRI outperforms 93.33% of its industry peers.
MCRI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.92
ROIC/WACC1.99
WACC8.85%
MCRI Yearly LT Debt VS Equity VS FCFMCRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 0.73 indicates that MCRI may have some problems paying its short term obligations.
MCRI has a Current ratio of 0.73. This is in the lower half of the industry: MCRI underperforms 61.48% of its industry peers.
MCRI has a Quick Ratio of 0.73. This is a bad value and indicates that MCRI is not financially healthy enough and could expect problems in meeting its short term obligations.
MCRI has a Quick ratio of 0.67. This is in the lower half of the industry: MCRI underperforms 61.48% of its industry peers.
MCRI does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 0.73
Quick Ratio 0.67
MCRI Yearly Current Assets VS Current LiabilitesMCRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 24.30% over the past year.
Measured over the past years, MCRI shows a very strong growth in Earnings Per Share. The EPS has been growing by 23.69% on average per year.
Looking at the last year, MCRI shows a small growth in Revenue. The Revenue has grown by 4.64% in the last year.
MCRI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.95% yearly.
EPS 1Y (TTM)24.3%
EPS 3Y12.04%
EPS 5Y23.69%
EPS Q2Q%21.01%
Revenue 1Y (TTM)4.64%
Revenue growth 3Y9.71%
Revenue growth 5Y15.95%
Sales Q2Q%6.84%

3.2 Future

MCRI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.43% yearly.
Based on estimates for the next years, MCRI will show a small growth in Revenue. The Revenue will grow by 3.33% on average per year.
EPS Next Y12.21%
EPS Next 2Y9.04%
EPS Next 3Y6.43%
EPS Next 5YN/A
Revenue Next Year5.89%
Revenue Next 2Y5.04%
Revenue Next 3Y3.33%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MCRI Yearly Revenue VS EstimatesMCRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
MCRI Yearly EPS VS EstimatesMCRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 18.63, MCRI is valued on the expensive side.
Based on the Price/Earnings ratio, MCRI is valued a bit cheaper than 71.85% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.76. MCRI is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 16.84, which indicates a correct valuation of MCRI.
MCRI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MCRI is cheaper than 67.41% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of MCRI to the average of the S&P500 Index (23.21), we can say MCRI is valued slightly cheaper.
Industry RankSector Rank
PE 18.63
Fwd PE 16.84
MCRI Price Earnings VS Forward Price EarningsMCRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

69.63% of the companies in the same industry are more expensive than MCRI, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, MCRI is valued a bit cheaper than the industry average as 78.52% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.36
EV/EBITDA 9.55
MCRI Per share dataMCRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

MCRI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of MCRI may justify a higher PE ratio.
PEG (NY)1.53
PEG (5Y)0.79
EPS Next 2Y9.04%
EPS Next 3Y6.43%

3

5. Dividend

5.1 Amount

MCRI has a Yearly Dividend Yield of 1.14%. Purely for dividend investing, there may be better candidates out there.
MCRI's Dividend Yield is a higher than the industry average which is at 6.99.
With a Dividend Yield of 1.14, MCRI pays less dividend than the S&P500 average, which is at 2.44.
Industry RankSector Rank
Dividend Yield 1.14%

5.2 History

MCRI has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
MCRI Yearly Dividends per shareMCRI Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

MCRI pays out 28.06% of its income as dividend. This is a sustainable payout ratio.
DP28.06%
EPS Next 2Y9.04%
EPS Next 3Y6.43%
MCRI Yearly Income VS Free CF VS DividendMCRI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
MCRI Dividend Payout.MCRI Dividend Payout, showing the Payout Ratio.MCRI Dividend Payout.PayoutRetained Earnings

MONARCH CASINO & RESORT INC

NASDAQ:MCRI (10/7/2025, 8:00:01 PM)

After market: 99.11 0 (0%)

99.11

-1.29 (-1.28%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)07-16 2025-07-16/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners66.6%
Inst Owner Change0%
Ins Owners23.21%
Ins Owner Change1%
Market Cap1.81B
Analysts74.55
Price Target102.2 (3.12%)
Short Float %1.64%
Short Ratio1.95
Dividend
Industry RankSector Rank
Dividend Yield 1.14%
Yearly Dividend1.19
Dividend Growth(5Y)N/A
DP28.06%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-29 2025-08-29 (0.3)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.38%
Min EPS beat(2)4.02%
Max EPS beat(2)18.74%
EPS beat(4)4
Avg EPS beat(4)12.26%
Min EPS beat(4)4.02%
Max EPS beat(4)20.88%
EPS beat(8)5
Avg EPS beat(8)2.67%
EPS beat(12)6
Avg EPS beat(12)1.12%
EPS beat(16)9
Avg EPS beat(16)1.98%
Revenue beat(2)2
Avg Revenue beat(2)1.81%
Min Revenue beat(2)0.23%
Max Revenue beat(2)3.39%
Revenue beat(4)4
Avg Revenue beat(4)1.67%
Min Revenue beat(4)0.23%
Max Revenue beat(4)3.39%
Revenue beat(8)5
Avg Revenue beat(8)0.82%
Revenue beat(12)7
Avg Revenue beat(12)0.8%
Revenue beat(16)9
Avg Revenue beat(16)1.62%
PT rev (1m)0.8%
PT rev (3m)13.86%
EPS NQ rev (1m)0.22%
EPS NQ rev (3m)5.57%
EPS NY rev (1m)0.09%
EPS NY rev (3m)7.82%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)2.56%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)2.45%
Valuation
Industry RankSector Rank
PE 18.63
Fwd PE 16.84
P/S 3.39
P/FCF 17.36
P/OCF 12.18
P/B 3.36
P/tB 3.53
EV/EBITDA 9.55
EPS(TTM)5.32
EY5.37%
EPS(NY)5.89
Fwd EY5.94%
FCF(TTM)5.71
FCFY5.76%
OCF(TTM)8.14
OCFY8.21%
SpS29.27
BVpS29.52
TBVpS28.04
PEG (NY)1.53
PEG (5Y)0.79
Profitability
Industry RankSector Rank
ROA 11.15%
ROE 14.59%
ROCE 22.75%
ROIC 17.6%
ROICexc 20.14%
ROICexgc 21.3%
OM 24.09%
PM (TTM) 14.72%
GM 54.43%
FCFM 19.51%
ROA(3y)11.75%
ROA(5y)9.74%
ROE(3y)15.45%
ROE(5y)13.62%
ROIC(3y)16.41%
ROIC(5y)13.04%
ROICexc(3y)17.94%
ROICexc(5y)14.16%
ROICexgc(3y)18.89%
ROICexgc(5y)14.91%
ROCE(3y)21.22%
ROCE(5y)16.86%
ROICexcg growth 3Y10.75%
ROICexcg growth 5Y23.79%
ROICexc growth 3Y10.64%
ROICexc growth 5Y23.89%
OM growth 3Y-1.11%
OM growth 5Y7.55%
PM growth 3Y-7%
PM growth 5Y1.78%
GM growth 3Y-0.78%
GM growth 5Y1.1%
F-Score7
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 83.34%
Cap/Sales 8.3%
Interest Coverage 156.5
Cash Conversion 81.68%
Profit Quality 132.59%
Current Ratio 0.73
Quick Ratio 0.67
Altman-Z 8.92
F-Score7
WACC8.85%
ROIC/WACC1.99
Cap/Depr(3y)95.66%
Cap/Depr(5y)184.37%
Cap/Sales(3y)9.04%
Cap/Sales(5y)17.42%
Profit Quality(3y)131.09%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.3%
EPS 3Y12.04%
EPS 5Y23.69%
EPS Q2Q%21.01%
EPS Next Y12.21%
EPS Next 2Y9.04%
EPS Next 3Y6.43%
EPS Next 5YN/A
Revenue 1Y (TTM)4.64%
Revenue growth 3Y9.71%
Revenue growth 5Y15.95%
Sales Q2Q%6.84%
Revenue Next Year5.89%
Revenue Next 2Y5.04%
Revenue Next 3Y3.33%
Revenue Next 5YN/A
EBIT growth 1Y9.89%
EBIT growth 3Y8.5%
EBIT growth 5Y24.7%
EBIT Next Year68.98%
EBIT Next 3Y20.95%
EBIT Next 5Y16.49%
FCF growth 1Y-20.42%
FCF growth 3Y4.73%
FCF growth 5YN/A
OCF growth 1Y-11.01%
OCF growth 3Y3.18%
OCF growth 5Y17.36%